| 前收市價 | 5.80 |
| 開市 | 無 |
| 買盤 | 12.50 |
| 賣出價 | 13.60 |
| 拍板 | 33.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 5.80 - 5.80 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 11 |
ZacksAvidity (RNA) Up 33% on Rare Muscle Disease Study Results
Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.
Investor's Business DailyThe 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
Avidity unveiled "impressive" results from a study of its treatment for a rare form of muscular dystrophy. The top biotech stock soared.
Motley Fool2 Potentially High-Reward Growth Stocks to Buy Right Now
These two biotechnology stocks could be gearing up for a run.
